A new class of 2-(4-cyanophenyl amino)-4-(6-bromo-4-quinolinyloxy)-6-piperazinyl (piperidinyl)-1,3,5-triazine analogues with antimicrobial/antimycobacterial activity

References

• Nathan C. Antibiotics at the crossroads. Nature 2004;431:899–902.
   PubMed Web of Science ®Google Scholar
• Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 2003;83:4–14.
   PubMed Web of Science ®Google Scholar
• NIAID. http://www3.niaid.nih.gov/topics/tuberculosis/.
   Google Scholar
• TAACF. http://www.taacf.org/about-TB-background.htm.
   Google Scholar
• World Health Organization, Global tuberculosis control: A short update to the 2009 report. http://www.who.int/tb/publications/global_report/2009/update/en/index.html.
   Google Scholar
• Mahajan DH, Pannecouque C, De Clercq E, Chikhalia KH. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents. Arch Pharm (Weinheim) 2009;342:281–290.
   PubMed Web of Science ®Google Scholar
• Chikhalia KH, Patel MJ. Design, synthesis and evaluation of some 1,3,5-triazinyl urea and thiourea derivatives as antimicrobial agents. J Enzyme Inhib Med Chem 2009;24:960–966.
   PubMed Web of Science ®Google Scholar
• Patel DH, Chikhalia KH, Shah NK, Patel DP, Kaswala PB, Buha VM. Synthesis and antimicrobial studies of s-triazine based heterocycles. J Enzyme Inhib Med Chem 2010;25:121–125.
   PubMed Web of Science ®Google Scholar
• Zhou C, Min J, Liu Z, Young A, Deshazer H, Gao T et al. Synthesis and biological evaluation of novel 1,3,5-triazine derivatives as antimicrobial agents. Bioorg Med Chem Lett 2008;18:1308–1311.
   PubMed Web of Science ®Google Scholar
• Srinivas K, Srinivas U, Bhanuprakash K, Harakishore K, Murthy US, Rao VJ. Synthesis and antibacterial activity of various substituted s-triazines. Eur J Med Chem 2006;41:1240–1246.
   PubMed Web of Science ®Google Scholar
• Baliani A, Bueno GJ, Stewart ML, Yardley V, Brun R, Barrett MP, Gilbert IH. Synthesis and antibacterial activity of various substituted s-triazines. Eur J Med Chem 2006;41:1240–1246.
   PubMed Web of Science ®Google Scholar
• Menicagli R, Samaritani S, Signore G, Vaglini F, Dalla Via L. In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research. J Med Chem 2004;47:4649–4652.
   PubMed Web of Science ®Google Scholar
• Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A et al. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg Med Chem Lett 2005;15:3102–3108.
   PubMed Web of Science ®Google Scholar
• Melato S, Prosperi D, Coghi P, Basilico N, Monti D. A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: combining conventional synthesis and microwave-assistance. Chemmedchem 2008;3:873–876.
   PubMed Web of Science ®Google Scholar
• Xiong YZ, Chen FE, Balzarini J, De Clercq E, Pannecouque C. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity. Eur J Med Chem 2008;43:1230–1236.
   PubMed Web of Science ®Google Scholar
• Kerns RJ, Rybak MJ, Kaatz GW, Vaka F, Cha R, Grucz RG et al. Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus. Bioorg Med Chem Lett 2003;13:2109–2112.
   PubMed Web of Science ®Google Scholar
• Singh KK, Joshi SC, Mathela CS. Synthesis and in-vitro antibacterial activity of N-alkyl and N-aryl piperazine derivatives. Ind J Chem 2011;50(B):196–200.
   Google Scholar
• Upadhayaya RS, Sinha N, Jain S, Kishore N, Chandra R, Arora SK. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol. Bioorg Med Chem 2004;12:2225–2238.
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Vandavasi JK, Kardile RA, Lahore SV, Dixit SS, Deokar HS et al. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents. Eur J Med Chem 2010;45:1854–1867.
   PubMed Web of Science ®Google Scholar
• Kumar CS, Vinaya K, Chandra JN, Thimmegowda NR, Prasad SB, Sadashiva CT et al. Synthesis and antimicrobial studies of novel 1-benzhydryl-piperazine sulfonamide and carboxamide derivatives. J Enzyme Inhib Med Chem 2008;23:462–469.
   PubMed Web of Science ®Google Scholar
• Sunduru N, Gupta L, Chaturvedi V, Dwivedi R, Sinha S, Chauhan PM. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Eur J Med Chem 2010;45:3335–3345.
   PubMed Web of Science ®Google Scholar
• Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005;307:223–227.
   PubMed Web of Science ®Google Scholar
• Rustomjee R, Diacon AH, Allen J, Venter A, Reddy C, Patientia RF et al. Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis. Antimicrob Agents Chemother 2008;52:2831–2835.
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Lahore SV, Sayyed AY, Dixit SS, Shinde PD, Chattopadhyaya J. Conformationally-constrained indeno[2,1-c]quinolines—a new class of anti-mycobacterial agents. Org Biomol Chem 2010;8:2180–2197.
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Shinde PD, Sayyed AY, Kadam SA, Bawane AN, Poddar A et al. Synthesis and structure of azole-fused indeno[2,1-c]quinolines and their anti-mycobacterial properties. Org Biomol Chem 2010;8:5661–5673.
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Shinde PD, Kadam SA, Bawane AN, Sayyed AY, Kardile RA et al. Synthesis and antimycobacterial activity of prodrugs of indeno[2,1-c]quinoline derivatives. Eur J Med Chem 2011;46:1306–1324.
   PubMed Web of Science ®Google Scholar
• Xiong YZ, Chen FE, Balzarini J, De Clercq E, Pannecouque C. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain. Chem Biodivers 2009;6:561–568.
   PubMed Web of Science ®Google Scholar
• Patel RV, Kumari P, Chikhalia KH. Novel s-triazinyl piperazines: Design, synthesis, characterization and anti-microbial activity. Arch Appl Sci Res 2010;2:232–240.
   Google Scholar
• Gillespie SH. Medical microbiology-Illustrated, Butterworth Heinemann Ltd., United Kingdom: 1994:234–247.
   Google Scholar
• Hawkey PM, Lewis DA. Medical bacteriology—a practical approach. Oxford University Press, United Kingdom: 1994:181–194.
   Google Scholar
• Anargyros P, Astill DS, Lim IS. Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J Clin Microbiol 1990;28:1288–1291.
   PubMed Web of Science ®Google Scholar
• Isenberg HD. Clinical microbiology procedures handbook, vol. 1, American Society for Microbiology, Washington, D.C. 1992.
   Google Scholar
• Patel NB, Khan IH, Rajani SD. Antimycobacterial and antimicrobial study of new 1,2,4-triazoles with benzothiazoles. Arch Pharm (Weinheim) 2010;343:692–699.
   PubMed Web of Science ®Google Scholar
• Dandia A, Arya K, Sati M, Sarawgi P. Green chemical synthesis of fluorinated 1,3,5-triaryl-s-triazines in aqueous medium under microwaves as potential antifungal agents. J Fluorine Chem 2004;125:1273–1277.
   Web of Science ®Google Scholar